| Dr Adam Vaughn, DO | |
|
1500 E Sherman Blvd, Muskegon, MI 49444 | |
| (231) 672-3883 | |
| (231) 672-3973 |
| Full Name | Dr Adam Vaughn |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 1500 E Sherman Blvd, Muskegon, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881081099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 5101021579 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 5101021579 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
News Archive
A new application note from Porvair Sciences details a protocol for its Chromatrap® ChIP assay kit that has been developed to enrich epigenetic marks from primary human tissue cells.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
The effort to drag the health-care industry into the technology age trudges onward, and it's still not clear whether the nation's 500,000 to 600,000 physicians will successfully make the journey. That's the finding from a number of health-care industry officials charged with pulling the medical profession into the 21st Century when it comes to managing patient records as well as automating the back-office operations of hospitals and clinics.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Being able to regulate your emotions is important for well-being, but new research suggests that a common emotion regulation strategy called "cognitive reappraisal" may actually be harmful when it comes to stressors that are under our control. The study is published in Psychological Science, a journal of the Association for Psychological Science.
› Verified 6 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
A new application note from Porvair Sciences details a protocol for its Chromatrap® ChIP assay kit that has been developed to enrich epigenetic marks from primary human tissue cells.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
The effort to drag the health-care industry into the technology age trudges onward, and it's still not clear whether the nation's 500,000 to 600,000 physicians will successfully make the journey. That's the finding from a number of health-care industry officials charged with pulling the medical profession into the 21st Century when it comes to managing patient records as well as automating the back-office operations of hospitals and clinics.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Being able to regulate your emotions is important for well-being, but new research suggests that a common emotion regulation strategy called "cognitive reappraisal" may actually be harmful when it comes to stressors that are under our control. The study is published in Psychological Science, a journal of the Association for Psychological Science.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Vaughn, DO Po Box 1847, Muskegon, MI 49443-1847 Ph: (866) 611-1512 | Dr Adam Vaughn, DO 1500 E Sherman Blvd, Muskegon, MI 49444 Ph: (231) 672-3883 |
News Archive
A new application note from Porvair Sciences details a protocol for its Chromatrap® ChIP assay kit that has been developed to enrich epigenetic marks from primary human tissue cells.
As hospitals look for ways to stem the opioid crisis, a survey of health-system pharmacy directors released today found that most large health systems have active stewardship programs to prevent the misuse of opioids - with pharmacists playing a key role in detecting drug diversion and identifying strategies to encourage appropriate opioid prescribing.
The effort to drag the health-care industry into the technology age trudges onward, and it's still not clear whether the nation's 500,000 to 600,000 physicians will successfully make the journey. That's the finding from a number of health-care industry officials charged with pulling the medical profession into the 21st Century when it comes to managing patient records as well as automating the back-office operations of hospitals and clinics.
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Being able to regulate your emotions is important for well-being, but new research suggests that a common emotion regulation strategy called "cognitive reappraisal" may actually be harmful when it comes to stressors that are under our control. The study is published in Psychological Science, a journal of the Association for Psychological Science.
› Verified 6 days ago
Edward Tanudjaja, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 | |
Dr. Karen A Thornburg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Baker St Fl 3, Muskegon, MI 49444 Phone: 231-737-1335 Fax: 231-737-0534 | |
Mathew J Brakora, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883 | |
Abbaseh Saedi, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1150 E Sherman Blvd Ste 1175, Muskegon, MI 49444 Phone: 231-672-6740 | |
Dr. Jon Hinderer, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 684 Harvey St, Muskegon, MI 49442 Phone: 231-777-5906 Fax: 231-773-8904 | |
Krishna Chaitanya Meka, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2009 Holton Rd, Muskegon, MI 49445 Phone: 616-935-3479 | |
Dr. Nino Pio Soave, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2009 Holton Rd, Muskegon, MI 49445 Phone: 616-267-7414 |